<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>ASTRAZENECA EARNINGS RISE</title>
    <meta content="MB234922" name="slug"/>
    <meta content="2" name="publication_day_of_month"/>
    <meta content="8" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Wednesday" name="publication_day_of_week"/>
    <meta content="Business/Financial Desk" name="dsk"/>
    <meta content="4" name="print_page_number"/>
    <meta content="C" name="print_section"/>
    <meta content="5" name="print_column"/>
    <meta content="Business" name="online_sections"/>
    <docdata>
      <doc-id id-string="1219543"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="WORLD BUSINESS BRIEFING: EUROPE"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Company Reports</classifier>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <location class="indexing_service">Europe</location>
        <org class="indexing_service">Astrazeneca Plc</org>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business/World Business</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Pharmaceutical, Biotechnology and Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Features/Travel/Guides/Destinations/Europe</classifier>
        <classifier class="online_producer" type="general_descriptor">Company Reports</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Corporations</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000802T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=950DE2D81E3DF931A3575BC0A9669C8B63" item-length="46" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>ASTRAZENECA EARNINGS RISE</hl1>
      </hedline>
      <byline class="print_byline">By Andrew Ross Sorkin</byline>
      <abstract>
        <p>AstraZeneca PLC, Europe's largest drug company, says its first-quarter earnings rose $2.4 billion from $2 billion a year earlier (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>Europe's largest drug company, AstraZeneca P.L.C., said its first-quarter earnings rose 19 percent. Pretax profit jumped to $2.4 billion from $2 billion a year earlier. AstraZeneca shares rose 47 pence, to 2,923 pence.</p>
        <p>Andrew Ross Sorkin (NYT)</p>
      </block>
      <block class="full_text">
        <p>Europe's largest drug company, AstraZeneca P.L.C., said its first-quarter earnings rose 19 percent. Pretax profit jumped to $2.4 billion from $2 billion a year earlier. AstraZeneca shares rose 47 pence, to 2,923 pence.</p>
        <p>Andrew Ross Sorkin (NYT)</p>
        <p>WORLD BUSINESS BRIEFING: EUROPE</p>
      </block>
    </body.content>
  </body>
</nitf>
